Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Crossover Pharmacokinetic Study of Tobramycin Administered for Inhalation by PARI eFlow® Rapid Electronic Nebulizer (no Compressor) vs. PARI LC PLUSTM Jet Nebulizer (With Compressor) in Cystic Fibrosis Subjects

NCT00420836 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00420836
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00420836 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Crossover Pharmacokinetic Study of Tobramycin Administered for Inhalation by PARI eFlow® Rapid Electronic Nebulizer (no Compressor) vs. PARI LC PLUSTM Jet Nebulizer (With Compressor) in Cystic Fibrosis Subjects
Lead sponsor
Novartis
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2006
Completion date
Not reported
Enrollment
20
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis